Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09197ExperimentalSmall molecule
Mepiprazole is a minor tranquilizer with a phenylpiperazine structure. It is a pyrazolyl-alkyl-piperazine derivative. Mepiprazole mediates a weak inhibitory action on the uptake of 5-HT on hypothalamic neurons . Mepiprazole... Mepiprazole is marketed in Spain for the treatment of anxiety neuroses.
- Primary indication
- For the treatment of anxiety neuroses.Curator reviewed
- Formula / weight
- C16H21ClN4 · 304.82 g/mol (avg)
- Code names
- EMD-16923
Resolves to
Structure
InChIKey
DOTIMEKVTCOGED-UHFFFAOYSA-NSMILES[H]N1N=C(CCN2CCN(CC2)C2=CC(Cl)=CC=C2)C=C1CWhat you can answer from here — as of August 30, 2026
Which companies are running trials of Mepiprazole, in which indications and phases, and which of those programs are still active?